BRIEF published on 08/14/2025 at 09:05, 20 days ago Travelex Issuerco 2 Plc publie ses résultats du deuxième trimestre 2025 Performance Financière Bourse De Londres Relations Avec Les Investisseurs Résultats Du Deuxième Trimestre Travelex
BRIEF published on 08/14/2025 at 09:05, 20 days ago Travelex Issuerco 2 Plc Releases Q2 2025 Results London Stock Exchange Financial Performance Investor Relations Q2 Results Travelex
PRESS RELEASE published on 08/14/2025 at 09:00, 20 days ago Q2 Results Travelex Issuerco 2 Plc announces Q2 2025 results. Access the results via provided link. Contact for investors: Victoria.Benis-Lonsdale@travelex.com London Stock Exchange Financial Report Travelex Issuerco 2 Plc Investor Queries Q2 Results
BRIEF published on 07/29/2025 at 10:50, 1 month 4 days ago Travelex Appoints Philip Bowcock as New CEO Market Strategy CEO Appointment Foreign Exchange Travelex Leadership Philip Bowcock
BRIEF published on 07/29/2025 at 10:50, 1 month 4 days ago Travelex nomme Philip Bowcock au poste de PDG Stratégie De Marché Nomination Du PDG Change Direction De Travelex Philippe Bowcock
PRESS RELEASE published on 07/29/2025 at 10:45, 1 month 4 days ago Travelex appoints new CEO Travelex, a leading foreign exchange brand, appoints Philip Bowcock as new CEO, effective 4 August 2025, succeeding Richard Wazacz. Philip has notable leadership experience in various industries CEO Travelex Leadership Experience Foreign Exchange Philip Bowcock
BRIEF published on 05/15/2025 at 09:35, 3 months 19 days ago Travelex Issuerco 2 Plc Reports First Quarter 2025 Results Financial Results Regulatory Compliance Vienna Stock Exchange Investor Inquiries Travelex Q1 2025
BRIEF published on 05/15/2025 at 09:35, 3 months 19 days ago Travelex Issuerco 2 Plc publie ses résultats du premier trimestre 2025 Résultats Financiers Conformité Réglementaire Bourse De Vienne Travelex T1 2025 Demandes Des Investisseurs
PRESS RELEASE published on 05/15/2025 at 09:30, 3 months 19 days ago 1st Quarter Results Travelex Issuerco 2 Plc announces first quarter results for 2025. Access the Q1 Results via the provided link. Contact for investor and other inquiries included London Stock Exchange EQS News Travelex Issuerco 2 Plc Investor Queries First Quarter Results
BRIEF published on 04/16/2025 at 13:00, 4 months 16 days ago Travelex finalise les modifications apportées aux actes de fiducie Travelex Amendements Notes De Premier Rang Sollicitation De Consentement Actes De Fiducie
Published on 09/03/2025 at 09:01, 36 minutes ago Apex Critical Metals Expands Strategic Focus with U.S. Critical Minerals Property Acquisition
Published on 09/03/2025 at 08:05, 1 hour 32 minutes ago Tocvan Announces Significant Funding and Strategic Webinar to Detail Gran Pilar Gold - Silver Project Next Steps to Production
Published on 09/03/2025 at 06:20, 3 hours 17 minutes ago Prince Silver Announces Non-brokered Private Placement
Published on 09/03/2025 at 04:05, 5 hours 32 minutes ago Diveroli Investment Group Files 13D on Wheeler REIT, Highlights Major Value Disconnect in Grocery-Anchored Portfolio
Published on 09/02/2025 at 22:40, 10 hours 57 minutes ago CoTec Holdings Corp. Announces Analyst Coverage Report by ECM Capital Advisors Ltd
Published on 09/03/2025 at 09:00, 36 minutes ago Original-Research: Deutsche Beteiligungs AG (von NuWays AG): BUY
Published on 09/03/2025 at 08:35, 1 hour 2 minutes ago Last day of trading in unit rights in Eurobattery Minerals rights issue
Published on 09/03/2025 at 08:33, 1 hour 3 minutes ago EQS-Adhoc: Deutsche Lufthansa AG: Deutsche Lufthansa Aktiengesellschaft launches the offering of EUR 600 million convertible bonds due 2032 and invites holders of outstanding convertible bonds due 2025 to submit
Published on 09/03/2025 at 08:30, 1 hour 6 minutes ago Original-Research: Warimpex Finanz- und Beteiligungs AG (von East Value Research GmbH ): BUY
Published on 09/03/2025 at 07:00, 2 hours 37 minutes ago Biophytis obtient l'autorisation de l'EMA pour le lancement de son étude clinique de phase 2 dans l’obésité
Published on 09/03/2025 at 07:00, 2 hours 37 minutes ago Biophytis obtains EMA authorization to launch its Phase 2 clinical trial in obesity
Published on 09/02/2025 at 18:47, 14 hours 49 minutes ago Mise à jour de l’objectif d’EBITDA pour l’exercice 2025
Published on 09/02/2025 at 18:47, 14 hours 49 minutes ago Update of the EBITDA target for the 2025 fiscal year
Published on 09/02/2025 at 18:39, 14 hours 57 minutes ago EMOVA Group annonce le succès de son augmentation de capital d’un montant de près de 6.6 M€
